JP2006502250A5 - - Google Patents

Download PDF

Info

Publication number
JP2006502250A5
JP2006502250A5 JP2004525225A JP2004525225A JP2006502250A5 JP 2006502250 A5 JP2006502250 A5 JP 2006502250A5 JP 2004525225 A JP2004525225 A JP 2004525225A JP 2004525225 A JP2004525225 A JP 2004525225A JP 2006502250 A5 JP2006502250 A5 JP 2006502250A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004525225A
Other languages
English (en)
Other versions
JP2006502250A (ja
JP4451308B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2003/007736 external-priority patent/WO2004012773A1/en
Publication of JP2006502250A publication Critical patent/JP2006502250A/ja
Publication of JP2006502250A5 publication Critical patent/JP2006502250A5/ja
Application granted granted Critical
Publication of JP4451308B2 publication Critical patent/JP4451308B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

Figure 2006502250
JP2004525225A 2002-07-24 2003-07-16 ポリアルキレングリコール酸添加剤 Expired - Fee Related JP4451308B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39813702P 2002-07-24 2002-07-24
PCT/EP2003/007736 WO2004012773A1 (en) 2002-07-24 2003-07-16 Polyalkylene glycol acid additives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008182692A Division JP5112203B2 (ja) 2002-07-24 2008-07-14 ポリアルキレングリコール酸添加剤

Publications (3)

Publication Number Publication Date
JP2006502250A JP2006502250A (ja) 2006-01-19
JP2006502250A5 true JP2006502250A5 (ja) 2008-09-04
JP4451308B2 JP4451308B2 (ja) 2010-04-14

Family

ID=31495718

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004525225A Expired - Fee Related JP4451308B2 (ja) 2002-07-24 2003-07-16 ポリアルキレングリコール酸添加剤
JP2008182692A Expired - Fee Related JP5112203B2 (ja) 2002-07-24 2008-07-14 ポリアルキレングリコール酸添加剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008182692A Expired - Fee Related JP5112203B2 (ja) 2002-07-24 2008-07-14 ポリアルキレングリコール酸添加剤

Country Status (13)

Country Link
US (2) US7193031B2 (ja)
EP (1) EP1526872A1 (ja)
JP (2) JP4451308B2 (ja)
KR (1) KR100608415B1 (ja)
CN (1) CN100337689C (ja)
AR (1) AR040654A1 (ja)
AU (1) AU2003258518B2 (ja)
BR (1) BR0313212A (ja)
CA (1) CA2492775C (ja)
MX (1) MXPA05000796A (ja)
PL (1) PL375265A1 (ja)
RU (1) RU2318004C2 (ja)
WO (1) WO2004012773A1 (ja)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US7153829B2 (en) 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
ATE477020T1 (de) 2002-06-07 2010-08-15 Dyax Corp Prevention und verringerung von ischemia
EP1526872A1 (en) * 2002-07-24 2005-05-04 F. Hoffmann-La Roche Ag Polyalkylene glycol acid additives
WO2005021556A2 (en) * 2003-08-29 2005-03-10 Dyax Corp. Modified protease inhibitors
CA2536873C (en) * 2003-08-29 2019-09-10 Dyax Corp. Poly-pegylated protease inhibitors
WO2005089805A2 (en) * 2004-03-15 2005-09-29 Nektar Therapeutics Al, Corporation Polymer-based compositions and conjugates of hiv entry inhibitors
EP1753805A4 (en) * 2004-05-17 2009-11-25 Univ Mcmaster AGAINST BIOLOGICAL MOLECULES REACTIVE HYDROPHILIC SILICONE SURFACE
AU2005275108B2 (en) * 2004-07-16 2011-05-12 Nektar Therapeutics Conjugates of a GM-CSF moiety and a polymer
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
EP1922355B1 (en) * 2005-08-26 2009-03-11 Novo Nordisk A/S A method of modifying a macromolecular system
US8133707B2 (en) * 2006-01-17 2012-03-13 Enzon Pharmaceuticals, Inc. Methods of preparing activated polymers having alpha nitrogen groups
CL2008002053A1 (es) 2007-07-17 2009-05-22 Hoffmann La Roche Metodo para la purificacion de una eritropoyetina monopeguilada (epompeg) que consiste en proporcionar una solucion que contiene eritropoyetina mono, poli y no peguilada y hacerla pasar por dos pasos de cromatografia de intercambio cationico y metodo para producir epo mpeg que incluye metodo de purificacion.
CL2008002054A1 (es) 2007-07-17 2009-05-29 Hoffmann La Roche Metodo para la regeneracion de una columna de cromatografia de intercambio cationico despues de la elusion de eritropoyetina monopeguilada y metodo para obtener una eritropoyetina monopeguilada, incorporando el metodo de regeneracion de la columna de intercambio cationico.
WO2009026334A2 (en) * 2007-08-21 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
KR101671537B1 (ko) 2008-08-11 2016-11-01 넥타르 테라퓨틱스 다분지형 중합체 알카노에이트 컨쥬게이트
AU2010203712A1 (en) 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
JP6037841B2 (ja) 2010-01-06 2016-12-07 ダイアックス コーポレーション 血漿カリクレイン結合タンパク質
US10040761B2 (en) * 2010-06-25 2018-08-07 Nof Corporation Branched hetero polyethylene glycol and intermediate
WO2012088445A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of cabazitaxel-based compounds
WO2012088422A1 (en) 2010-12-22 2012-06-28 Nektar Therapeutics Multi-arm polymeric prodrug conjugates of taxane-based compounds
AU2012204202A1 (en) 2011-01-06 2013-07-11 Dyax Corp. Plasma kallikrein binding proteins
KR102076874B1 (ko) * 2012-04-03 2020-02-12 쉰들러, 윌리엄 숙신이미드-활성화 나이트록실 화합물 및 단백질의 나이트록실화를 위한 이의 사용 방법
CN102816227A (zh) * 2012-08-30 2012-12-12 深圳赛保尔生物药业有限公司 回收促红细胞生成素的方法
BR112015023233A8 (pt) 2013-03-15 2019-12-03 Sangart Inc conjugados de hemoglobina, composição farmacêutica e uso de um conjugado de hemoglobina
US10428158B2 (en) 2014-03-27 2019-10-01 Dyax Corp. Compositions and methods for treatment of diabetic macular edema
CN108602893A (zh) 2015-12-11 2018-09-28 戴埃克斯有限公司 血浆激肽释放酶抑制剂及其治疗遗传性血管性水肿发作的用途
US12018120B2 (en) 2019-03-29 2024-06-25 Nof Corporation Method for producing terminal carboxyl group-containing polyethylene glycol and method for producing activated polyethylene glycol

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5849450B2 (ja) 1975-07-09 1983-11-04 株式会社日立製作所 スイリヨクシキカプセルユソウソウチノ ボウシクホウ
DE3675588D1 (de) 1985-06-19 1990-12-20 Ajinomoto Kk Haemoglobin, das an ein poly(alkenylenoxid) gebunden ist.
JP2531661B2 (ja) 1987-02-25 1996-09-04 味の素株式会社 酸素運搬剤
US5595732A (en) 1991-03-25 1997-01-21 Hoffmann-La Roche Inc. Polyethylene-protein conjugates
US5382657A (en) 1992-08-26 1995-01-17 Hoffmann-La Roche Inc. Peg-interferon conjugates
EP0730470B1 (en) * 1993-11-10 2002-03-27 Enzon, Inc. Improved interferon polymer conjugates
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
TW517067B (en) 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
CZ300546B6 (cs) 1999-01-29 2009-06-10 Amgen, Inc. Fyziologicky aktivní konjugát, prostredek a zpusob prípravy
CO5160259A1 (es) 1999-03-02 2002-05-30 Schering Corp Interferon alfa pegilado en la terapia contra el hiv
CZ299516B6 (cs) 1999-07-02 2008-08-20 F. Hoffmann-La Roche Ag Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
BR9917517A (pt) 1999-10-08 2002-07-30 Shearwater Corp Derivados poliméricos heterobifuncionais e processo para a preparação dos mesmos
AU781839B2 (en) 1999-12-22 2005-06-16 Nektar Therapeutics Sterically hindered derivatives of water soluble polymers
US20020065397A1 (en) 2000-10-12 2002-05-30 Joseph Roberts Protecting therapeutic compositions from host-mediated inactivation
ATE505204T1 (de) * 2000-12-20 2011-04-15 Hoffmann La Roche Konjugate von erythropoietin (epo) mit polyethylenglykol (peg)
EP1526872A1 (en) * 2002-07-24 2005-05-04 F. Hoffmann-La Roche Ag Polyalkylene glycol acid additives

Similar Documents

Publication Publication Date Title
JP2006502250A5 (ja)
JP2007515381A5 (ja)
JP2006028409A5 (ja)
JP2005247844A5 (ja)
JP2007063520A5 (ja)
JP2006503960A5 (ja)
JP2006188651A5 (ja)
JP2008514623A5 (ja)
JP2006514019A5 (ja)
JP2004244619A5 (ja)
JP2004168997A5 (ja)
JP2007070320A5 (ja)
JP2003305787A5 (ja)
JP2006028280A5 (ja)
JP2005533836A5 (ja)
JP2006510481A5 (ja)
JP2005206527A5 (ja)
JP2005523387A5 (ja)
JP2004262980A5 (ja)
JP2006233098A5 (ja)
JP2005035984A5 (ja)
JP2005506321A5 (ja)
JP2005002267A5 (ja)
JP2004294750A5 (ja)
JP2006199628A5 (ja)